Delta Check Calculation Guide

Similar documents
CAP Laboratory Improvement Programs. Delta Check Practices and Outcomes

NORMAL LABORATORY VALUES FOR CHILDREN

Inspector's Accreditation Unit Activity Menu

Supplementary materials

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

Understanding Blood Tests

Tables of Normal Values (As of February 2005)

i. Where is the participant seen?

Evaluation Report of the Pneumatic Tube Transport System (PEVCO) connecting Dialysis Hospital to. Mubarak Hospital. Dr.

Clinician Blood Panel Results

Epic Labs Orderable As STAT PRIORITY As of 06/22/2016

What is PlaqueOff (PO)? A new study in Beagle dogs. Oral effects of

Rapid Laboratories In House Tests

ROUTINE LAB STUDIES. Routine Clinic Lab Studies

NEW RCPCH REFERENCE RANGES-

Comparison of VACUETTE Heparin Gel Tubes for Common Chemistry Analytes

Test Result Reference Range Flag

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers

MidMichigan Health LABORATORY POLICY Title: Effecti ve te: Key Words: places: Category: Applicability: reference laboratory

Evaluation of VACUETTE CAT Serum Fast Separator Blood Collection Tube for Routine Chemistry Analytes in Comparison to VACUTAINER RST Tube

Stability of VACUETTE Lithium Heparin Separator tubes with modified centrifugation conditions

PENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015

Complete Medical History

Hamilton Regional Laboratory Medicine Program

Clinician Blood Panel Results

10 Essential Blood Tests PART 1

M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017

Clinician Blood Panel Results

COMPANY OR UNIVERSITY

BC Biomedical Laboratories Adult Reference Ranges

Serodos and Serodos plus

Analyte Specimen Demographic Reference Range Units

Hamilton Regional Laboratory Medicine Program

Provided by MedicalStudentExams.com NORMAL LABORATORY VALUES

VITROS MicroSlide Assay Summary

MEDICAL HISTORY. 23-Jan-2018 to 23-Jan VCA Miller-Robertson Animal Hospital 8807 Melrose Ave, Los Angeles, CA (310)

What Does My Blood Test Mean

Multiphasic Blood Analysis

ENROLLMENT CONFIRMATION

SMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION

Specimen Collection Requirements

REFERENCE INTERVALS. Units Canine Feline Bovine Equine Porcine Ovine

Specimen Collection Requirements

SMALL ANIMAL SOFT TISSUE CASE- BASED EXAMINATION

JOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS. Always call results for the following test(s):

Conference. Clinical Chemistry 43: (1997) Oak Ridge

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined.

1.) 3 yr old FS Siamese cat: 3 day history of lethargy, anorexia. Dyspneic, thin, febrile.

Add your company slogan LOGO

Laboratory Values, Critical. ThedaCare. Date Last Reviewed: 4/5/2018 Reviewing Body(s): Quality; Laboratory Leadership

Get to know yourself better. Attend our health screening event.

Get to know yourself better. Attend our health screening event.

Documentation Dissection

Efficacy and safety of brexpiprazole for the treatment of acute. schizophrenia: a 6-week, randomized, double-blind, placebocontrolled

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)

Manufacturer Report for Siemens Unassayed Chemistry Lot Exp 30 Jun 2018

BIOCHEMICAL REPORT. Parameters Unit Finding Normal Value. Lipase U/L Amylase U/L

Comments / Frequency (if not each time)

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

Seeing is not Believing (13-Nov-2004)

1. HISTORY. This issue publishes a revision of this publication.

BASIC METABOLIC PANEL

Postanalytical phase

Online catalog

CASE-BASED SMALL GROUP DISCUSSION

CAP Laboratory Improvement Programs. Utility of Repeat Testing of Critical Values. A Q-Probes Analysis of 86 Clinical Laboratories

GRADING CRITERIA for CMS Regulated Analytes

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) LIST ON

Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University

Evaluation of new MiniCollect Z Serum (Separator) Tubes

Supplementary Note Details of the patient populations studied Strengths and weakness of the study

Therapeutic and Critical Drug Levels

The Blood Chemistry Panel Explained

CASE-BASED SMALL GROUP DISCUSSION

Routine Clinic Lab Studies

Cytochrome-C (rat, mouse) forward GGAGGCAAGCATAAGACTGG. mouse hexokinase 2 gene, intron 9 reverse GGGAACACAAAAGACCTCTTCTGG

WELLNESS LABS EXPLANATION OF RESULTS BASIC METABOLIC PANEL

Separation of Plasma and Serum and Their Proteins from Whole Blood

35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough

Supplementary Appendix

CME/SAM. An Examination of the Usefulness of Repeat Testing Practices in a Large Hospital Clinical Chemistry Laboratory

Total Cholesterol A Type of Fat. LDL "Bad" Cholesterol. HDL "Good" Cholesterol. Triglycerides Type of Fat. vldl-c Precursor to LDL Cholest

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO

Supplementary Figure 1. Western blot of hippocampal lysates from WT and Adcy1 KO mice demonstrates the specificity of the ADCY1 antibody.

LabDriver Audit Trail Example

Parkview Health Laboratories Health Fair Information

OHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST

Test Critical Low Critical High Alerting Category

CTAD as a universal anticoagulant

ROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE

no concerns hepatic shunt, high protein diet, kidney failure, metabolic acidosis

CLINICAL CHEMISTRY REAGENTS. Product Profile

CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE

Pediatric and Adult Reference Intervals for Chemistry, Immunoassay, and Hematology Markers based on the CHMS

Burak DiK 1, Emre BAHCIVAN 1,2, Hatice ESER 1,3, Kamil UNEY 1

THE "AVERAGE OF NORMALS" METHOD OF QUALITY CONTROL

Transcription:

Delta Check Calculation Guide National Technology 2017, All Rights Reserved By Senior Scientific Researcher, Asmaa Taher

Table of Contents Definition... 2 Purpose... 2 Delta Check Research Studies... 2 CAP Q-Probe... 2 Study conditions... 3 Observations... 3 Recommendations... 4 Actions taken... 4 Findings... 6 UAMS: University of Arkansas for Medical Science... 9 Findings... 9 Keep in mind 10 How to Calculate Delta Check Limits?... 11 Example... 11 References... 12 Page 1 of 12

Definition The Delta Check is a measurement of the difference between a patient s sequential test results, where a larger than expected interval change in results may indicate a testing problem associated with either the former or the current specimen and prompt an investigation before results are reported. Delta check can be expressed as the absolute or the percent difference between two consecutive results. Absolute value are calculated as the difference between the larger and smaller result. 1. Δ = X-x Percent delta are calculated as the difference between the larger result and the smaller result divided by the smaller result. 2. Δ% = (X-x)/x Where: X is the larger result / x is the smaller result Purpose 1. Delta checks are widely used in clinical laboratories as a patient-based quality assessment tool to detect errors associated with: a. Specimen collection b. Analysis c. Reporting problems 2. Provides a safety net for identifying testing errors that might otherwise go unnoticed. 3. An important component of auto-verification procedures that improve the laboratory s efficiency Delta Check Research Studies CAP Q-Probe The College of American Pathologists CAP worked on Delta Check Q-Probes study and published their results on April 2017. The goal of this Q-Probes research study is for making adjustments such as: a. Adding or removing analytes, b. Reviewing observations to determine the maximum number of days used in delta check calculations. Page 2 of 12

Study conditions 1. A total of 49 facilities participated in this study. 2. Among 4505 testing episodes involving 6541 delta check alerts. Testing episode: action of collecting samples and perform several tests on them. 3. The median frequencies of actions taken among 49 laboratories were: Action Taken Percentage % Clinical review 38.0 Retest of the current sample 25.0 Recheck of the current sample 20.2 Nothing 15.4 Analytical check 5.0 Other 2 Retest or check previous specimen 0 4. Time interval is the specimen collection time difference between the current and previous results. Time interval is flexible. Most hospital laboratories choose 24 or 48 hours. Maximum time interval was 14 days. 5. Delta checks are recommended for inpatient testing. Generally, you want to select the chemistry analytes that have the lowest biological variation. Observations 1. Among the 240 delta check testing problems identified, the most common were interference due to hemolysis, lipemia, or icterus, with IV fluid contamination which is somewhat less common. Analytical and other processing or handling errors represented very few of the testing problems. 2. The study authors thought of delta checks as a way of picking up misidentified specimens, but even with the large number of specimens in the study, there were only 11 instances of misidentification. Delta check is not as good for picking up mislabeling, which represented only 5% of testing problems and 0.3 % of all testing episodes. 3. 94% of the testing episodes involving delta checks involved no change in test results or suspected problems. Patient results were verified and released with no change. 4. What the study s authors found, when there is a delta check, some analytes are more effective at identifying problems. a. Analytes have the highest levels of relative performance: sodium, potassium, calcium, magnesium, MCV, mean corpuscular hemoglobin, Page 3 of 12

mean corpuscular hemoglobin concentration, red blood cell distribution width, hemoglobin or hematocrit, and platelet count. b. Less effective are: creatinine or blood urea nitrogen, albumin, chloride, phosphorus, white blood cell count, carbon dioxide, prothrombin time, and international normalized ratio of prothrombin time of blood coagulation. c. The least effective are: total protein, bilirubin (total and direct), uric acid, aspartate aminotransferase, alkaline phosphatase, glucose, lactate dehydrogenase, gamma-glutamyltransferase, and cholesterol. 5. Delta check could be either absolute, percentage, or rate of change. The laboratories contributed in the study split using absolute value (52 %) and percentage (48 %). Laboratories did report using the absolute value more often than percentage for certain analytes, such as MCV, hemoglobin, potassium, and chloride, whereas they were likelier to use percentage more often for platelets and enzymes. 6. When you have a delta check, a problem could involve either the current sample or the previous one. Nevertheless, we found that previous samples were investigated much less often compared with the current sample. This was a striking difference, with current specimens checked 36 times more often than previous specimens even though 23.8 % of testing problems involved the previous specimen. 7. There was no action taken in response to a delta check 36 % or more of the time in facilities ranked above the 75th percentile. In 10 % of the laboratories, delta checks were not investigated in almost 80 % or more of cases. Ideally, if you have a delta check, you should always do something. Recommendations 1. The study authors recommend that laboratories consider using a checklist to better standardize investigation of the delta check. 2. Many of the significant delta checks identified specimen quality issues. 3. Investigate the previous sample as well as the current sample. Actions taken Table 1. Worksheet Categories for Actions, Problems, and Outcomes Used by Participants for Collecting Information about Delta Check Alerts None taken (current or previous specimens) Repeat testing (current or previous specimens) 1. Testing repeated from primary tube Page 4 of 12

2. Testing repeated from original aliquot 3. Testing repeated from new aliquot 4. Performed additional (non-ordered) tests 5. Checked for ABO discrepancy Specimen check (current or previous specimens) 1. Check for hemolysis, lipemia, and icterus. 2. Check for clot 3. Check for primary tube mislabeling 4. Check for aliquot mislabeling Analytical check (current specimen) 1. Checked other results on same run 2. Checked quality control 3. Retested quality control 4. Retested specimen after recalibration 5. Retested after instrument troubleshooting Clinical review 1. Checked blood transfusion history 2. Reviewed medical record 3. Contacted clinical personnel for more information Other actions 1. Checked LIS or interface 2. Rechecked calculations 3. Checked for discrepancies with other laboratory sections 4. Reviewed with technical supervisor 5. Reviewed with pathologist/laboratory director 6. Request new specimen 7. Checked for other pre-analytical problem(s) 8. Checked for other analytical problem(s) 9. Checked for other post-analytical problem(s) Test problem(s) suspected or confirmed (current or previous specimens) Problem 1. Analytical measurement error 2. Calculation error 3. Clotted specimen 4. Data entry error 5. Clerical error, other than data entry 6. Interface/data transmission error 7. Delay in processing 8. Delay in transport 9. Hemolysis, lipemia, icterus 10. Improper handling (temperature, light) Page 5 of 12

11. Improper processing (dilution, aliquot) 12. Mislabeled aliquot 13. Mislabeled specimen 14. Specimen contamination (e.g., IV fluid) 15. Wrong specimen container 16. Other problem (describe below) No problem identified 1. Cause for delta check is unexplained 2. Delta check caused by physiologic condition 3. Delta check caused blood transfusion 4. No testing problem, other cause not listed for delta check Findings Thirty analytes (30) were included in the study: 1. Chemistry: 20 2. CBC: 7 3. Coagulation: 3 Chemistry Page 6 of 12 Analytes Absolute Change Percentage Change % Sodium 9 meq/l 5 Calcium 2 mg/dl 15 Potassium 1 meq/l 20 Creatinine 1 mg/dl 30 BUN 20 mg/dl 50 Albumin 1 g/dl 20 Protein 2 g/dl 20 Total bilirubin 2 mg/dl 40 Chloride 10 meq/l 12 Phosphorus 2 mg/dl 50 CO2 8 meq/l 20 Magnesium 1 mg/dl 25 Uric acid 2 mg/dl 40 Direct bilirubin 2 mg/dl 80 AST --- 75 Alkaline phosphatase 20 U/L 50 Glucose 100 mg/dl 50 Lactate dehydrogenase 65 c-glutamyltransferase --- 75

Hematology Coagulation Cholesterol 70 mg/dl 30 MCV 4 fl 6 Hemoglobin 2 g/dl 20 Platelet count 50 000/lL 34 WBC count 5 000/lL 35 Hematocrit 6% 14 MCH 4 pg --- MCHC 2 g/l --- Prothrombin time --- 30 INR 1 28 Fibrinogen --- 75 Page 7 of 12

Page 8 of 12

UAMS: University of Arkansas for Medical Science Several medical facilities worked on Delta Check study individually and published the results. Here is one example from University of Arkansas for Medical Science UAMS Findings Chemistry (serum) Analyte Albumin Bilirubin *BUN Calcium (Ca) Carbon Dioxide Chloride (Cl) *Creatinine Magnesium Osmolality Potassium (K) Sodium (Na) Total Protein **Uric Acid Delta Check 2.0 g/dl 2.0 mg/dl 25 mg/dl 3.0 mg/dl 15 meq/l 15 meq/l 10 mg/dl 2.0 meq/l 20 mosm/kg 2.5 meq/l 15 meq/l 2.0 gm/dl 2.0 mg/dl * Non-Renal ** Non-Heme/Onc Page 9 of 12

Keep in mind: 1. Generally studies include inpatients over 18 years old. 2. Delta check limits may change with patient age: a. MCV elevations in neonates. b. Creatinine decreases with age, urea increases. 3. Different rules may be needed for different population. Ex. oncology, transplant. 4. These conditions should be considered in investigation checklist when Delta Check alarm set off. Page 10 of 12

How to Calculate Delta Check Limits? Setting the alerting limits of Delta Check through calculating RCV Reference Change Value (RCV): RCV = 2 0.5 * Z * (CV A 2 + CV I 2 ) 0.5 Z = For 2 tailed analyses: 1.96 at 95% probability ( significant ); 2.58 at 99% probability ( highly significant ) CV A = analytical variation (from QC) = SD/Mean * 100 CV I = intra-individual variation (from literature or http://www.westgard.com/biodatabase1.htm) Example Alkaline phosphatase internal QC has an SD of 0.56 U/L at a mean of 40 U/L. CV A = 0.56 / 40 * 100 = 1.4% Within subject biological variation (CV I ) is 6.4% Formula is: RCV =2 0.5 * Z * (CV A 2 + CV I 2 ) 0.5 RCV at 95% = 1.414 * 1.96 * (1.4 2 + 6.4 2 ) 0.5 = 18% RCV at 99% = 1.414 * 2.58 * (1.4 2 + 6.4 2 ) 0.5 = 24% Absolute value = Mean * RCV = 40 * 24% = 9.6 U/L This concludes the delta check calculation guide. Page 11 of 12

References http://www.captodayonline.com/delta-checks-safety-net-used-useful/ http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2016-0161- CP?code=coap-site http://www.uams.edu/clinlab/delta.htm http://www.arup.utah.edu/media/deltachecks/straseski%20deltacheck.pdf https://www.westgard.com/biodatabase1.htm http://www.qcnet.com/portals/49/pdfs/biological%20variation,%20a%20practical%2 0review,%20Dr%20C.%20Ricos.pdf Page 12 of 12